78 related articles for article (PubMed ID: 1626955)
1. [Combination chemotherapy of solid tumor--effects of hyaluronidase on doxorubicin (DXR) penetration into multicellular tumor spheroids (MTS)].
Kohno N; Ichikawa G; Kawasaki K; Kawaida M; Ohnuma T
Gan To Kagaku Ryoho; 1992 Jul; 19(7):981-6. PubMed ID: 1626955
[TBL] [Abstract][Full Text] [Related]
2. Effects of hyaluronidase on doxorubicin penetration into squamous carcinoma multicellular tumor spheroids and its cell lethality.
Kohno N; Ohnuma T; Truog P
J Cancer Res Clin Oncol; 1994; 120(5):293-7. PubMed ID: 8126058
[TBL] [Abstract][Full Text] [Related]
3. Effects of doxorubicin and cisplatin on multicellular tumor spheroids from human lung cancer.
Inoue S; Ohnuma T; Takaoka K; Suzuki Y; Kaneko M; Safirstein R; Holland JF
Cancer Drug Deliv; 1987; 4(4):213-24. PubMed ID: 3454248
[TBL] [Abstract][Full Text] [Related]
4. Interactions of doxorubicin and cis-platin in squamous carcinoma cells in culture.
Kohno N; Ohnuma T; Kaneko M; Holland JF
Br J Cancer; 1988 Sep; 58(3):330-4. PubMed ID: 3179185
[TBL] [Abstract][Full Text] [Related]
5. Effects of anticancer agents on the shedding of cells from human multicellular tumor spheroids.
Kohno N; Ohnuma T; Holland JF; Biller H
Invasion Metastasis; 1987; 7(5):264-74. PubMed ID: 3679741
[TBL] [Abstract][Full Text] [Related]
6. Effects of physiological oxygen environment on drug-induced cell lethality of multicellular tumor spheroids from human lung cancer.
Inoue S; Ohnuma T
Sel Cancer Ther; 1989; 5(1):13-22. PubMed ID: 2756245
[TBL] [Abstract][Full Text] [Related]
7. Synergistic interaction of natural human tumor necrosis factor-alpha/natural human interferon-alpha mixture alone and in combination with cisplatin against head and neck laryngeal squamous carcinoma multicellular tumor spheroids.
Kohno N; Ohnuma T; Kawaida M; Ichikawa G
Auris Nasus Larynx; 1993; 20(1):53-62. PubMed ID: 8323491
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity of adriamycin in MGH-U1 cells grown as monolayer cultures, spheroids, and xenografts in immune-deprived mice.
Erlichman C; Vidgen D
Cancer Res; 1984 Nov; 44(11):5369-75. PubMed ID: 6488191
[TBL] [Abstract][Full Text] [Related]
9. Combined activity of interleukin-1 alpha or TNF-alpha and doxorubicin on multidrug resistant cell lines: evidence that TNF and DXR have synergistic antitumor and differentiation-inducing effects.
Borsellino N; Crescimanno M; Flandina C; Flugy A; D'Alessandro N
Anticancer Res; 1994; 14(6B):2643-8. PubMed ID: 7872695
[TBL] [Abstract][Full Text] [Related]
10. Oxygen tensions in two human tumor cell lines grown and irradiated as multicellular spheroids.
Schwachöfer JH; Acker H; Crooijmans RP; Van Gasteren JJ; Holtermann G; Hoogenhout J; Jerusalem CR; Kal HB
Anticancer Res; 1991; 11(1):273-9. PubMed ID: 2018361
[TBL] [Abstract][Full Text] [Related]
11. Effects of folinic acid on 5-fluorouracil induced cell lethality with or without cisplatin against head and neck laryngeal squamous carcinoma multicellular tumor spheroids.
Kohno N; Ohnuma T; Kawaida M; Kawasaki K; Ichikawa G
Acta Otolaryngol; 1992; 112(3):566-73. PubMed ID: 1441999
[TBL] [Abstract][Full Text] [Related]
12. Induction of cell death by Doxorubicin in multicellular spheroids as studied by confocal laser scanning microscopy.
Wartenberg M; Acker H
Anticancer Res; 1996; 16(2):573-9. PubMed ID: 8687100
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide attenuates resistance to doxorubicin in three-dimensional aggregates of human breast carcinoma cells.
Muir CP; Adams MA; Graham CH
Breast Cancer Res Treat; 2006 Mar; 96(2):169-76. PubMed ID: 16331349
[TBL] [Abstract][Full Text] [Related]
14. New potential therapy for orthotopic bladder carcinoma by combining HVJ envelope with doxorubicin.
Kawano H; Komaba S; Yamasaki T; Maeda M; Kimura Y; Maeda A; Kaneda Y
Cancer Chemother Pharmacol; 2008 May; 61(6):973-8. PubMed ID: 17653716
[TBL] [Abstract][Full Text] [Related]
15. The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis.
Tolomeo M; Dusonchet L; Meli M; Grimaudo S; D'Alessandro N; Papoff G; Ruberti G; Rausa L
Cell Death Differ; 1998 Sep; 5(9):735-42. PubMed ID: 10200532
[TBL] [Abstract][Full Text] [Related]
16. Increase of therapeutic effects by treating melanoma with targeted combinations of c-myc antisense and doxorubicin.
Pastorino F; Mumbengegwi DR; Ribatti D; Ponzoni M; Allen TM
J Control Release; 2008 Feb; 126(1):85-94. PubMed ID: 18166243
[TBL] [Abstract][Full Text] [Related]
17. Differential changes in purine nucleotides after Doxorubicin treatment of human cancer cells in vitro.
Walenta S; Feigk B; Wachsmuth I; Dunkern T; Degani H; Mueller-Klieser W
Int J Oncol; 2002 Aug; 21(2):289-96. PubMed ID: 12118323
[TBL] [Abstract][Full Text] [Related]
18. Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy.
Pastorino F; Brignole C; Marimpietri D; Cilli M; Gambini C; Ribatti D; Longhi R; Allen TM; Corti A; Ponzoni M
Cancer Res; 2003 Nov; 63(21):7400-9. PubMed ID: 14612539
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of recombinant human interleukin-1 alpha in doxorubicin-treated normal and tumor-bearing mice.
Lynch DH; Rubin AS; Miller RE; Williams DE
Cancer Res; 1993 Apr; 53(7):1565-70. PubMed ID: 8453624
[TBL] [Abstract][Full Text] [Related]
20. Cell shedding from x-irradiated multicellular spheroids of human lung carcinomas.
Sakata K; Okada S; Majima H; Suzuki N
Strahlenther Onkol; 1991 Dec; 167(12):723-5. PubMed ID: 1662416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
